$72.090
-5.378 (-7.46%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CYTK Prediction & Forecast by Similar Chart Analysis
Alphio's CYTK stock price prediction model matches the current Cytokinetics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $73.59 (+2.08%). The 1-week path is $74.01 (+2.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Cytokinetics Inc Stock?
Cytokinetics Inc is currently not a strong buy due to its low RSI of 25.889, indicating it is oversold, and the significant insider selling activity, where the CEO sold 7,500 shares. However, the stock has a positive long-term outlook with a projected price increase of nearly 40% and a solid 1-year change of +45.28%.
CYTK stock price ended at $72.09 on Friday, after losing -7.46%
Cytokinetics Inc (CYTK) last closed at $72.09, losing -7.46%. These facts feed the 1-day and 1-week CYTK price prediction above.
Analyst Consensus
Cytokinetics Inc (CYTK): 8 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Cytokinetics Inc (CYTK) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CYTK, ranked by similarity.
Seasonality analysis for CYTK
Historically the probability of a positive August return for CYTK is 31.75%. January offers the highest probability of a positive month at 55.74%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CYTK
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $84.41 | $86.15 | $88.74 | +19.51% |
| Sep 2026 | $72.17 | $75.76 | $78.54 | +5.10% |
| Oct 2026 | $48.94 | $66.30 | $82.43 | -8.03% |
| Nov 2026 | $85.33 | $90.35 | $95.49 | +25.33% |
| Dec 2026 | $69.92 | $98.42 | $102.97 | +36.53% |
In 2026, Cytokinetics Inc (CYTK) is projected to range from $48.94 to $102.97.
Cytokinetics Inc 2026 monthly forecast
In Aug 2026, Cytokinetics Inc is projected to average $86.15, with a low of $84.41 and high of $88.74.
In Sep 2026, Cytokinetics Inc is projected to average $75.76, with a low of $72.17 and high of $78.54.
In Oct 2026, Cytokinetics Inc is projected to average $66.30, with a low of $48.94 and high of $82.43.
In Nov 2026, Cytokinetics Inc is projected to average $90.35, with a low of $85.33 and high of $95.49.
In Dec 2026, Cytokinetics Inc is projected to average $98.42, with a low of $69.92 and high of $102.97.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.